Research Services

Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...

Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke. As a common underlying factor in so many preventable...

The health and behavior of each one of our cells is influenced by both genetics and epigenetics. Drug discovery has historically targeted proteins...

What is the most successful preclinical strategy for drug discovery? Finding the answer to this question is important if pharma is to keep its...

The internet has connected us in a way never before seen in history: we can now rely on other’s people experiences to guide our own. Whether it is...

Last month we ran a series of blog posts about next generation sequencing. Among the topics discussed were the limitations of next generation...

Here at Scientist, for the past few weeks we’ve been running a series of blog posts about stem cells discussing why iPS make an attractive research...

In our previous post on stem cells, we discussed how human-derived induced pluripotent stem cells (iPS) are being used to model “disease in a...

Last week we talked about Stem cell research getting the “green light” and this week we continue with our stem cell blog series. Biology has long...

One of Scientist’s most popular blog posts of last year was an infographic depicting American attitudes towards stem cell research. Part of that...